JFS WEALTH ADVISORS, LLC

Position in ALKS — Alkermes plc.

CIK 1568068 HERMITAGE, PA

Position in ALKS

as of Jun 30, 2026 · filed Jul 10, 2026 Compact

Position Value

$4,610

+$2,454 QoQ

Shares Held

+44.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#369

of 421 holders

Holding Since

Dec 2021

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

JFS WEALTH ADVISORS, LLC holds $229,680 across 22 Drug Manufacturers - Specialty & Generic names. ALKS ranks #8 (2.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VTRS	Viatris Inc	7,409	$117,654
2	UTHR	UNITED THERAPEUTICS Corp	54	$29,258
3	TEVA	Teva Pharmaceutical Industries Ltd	778	$26,358
4	ZTS	Zoetis Inc.	133	$9,557
5	ELAN	Elanco Animal Health Inc	373	$9,179
6	NBIX	Neurocrine Biosciences Inc	50	$8,427
7	HLN	Haleon plc	858	$8,005
8	ALKS	Alkermes plc. This page	88	$4,610

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,610	88	+44.3%	Shares	Sole	2026-07-10
2026-03-31	$2,156	61	-48.3%	Shares	Sole	2026-04-21
2025-12-31	$3,301	118	+53.2%	Shares	Sole	2026-01-14
2025-09-30	$2,310	77	0.0%	Shares	Sole	2025-11-10
2025-06-30	$2,202	77	-1.3%	Shares	Sole	2025-07-24
2025-03-31	$2,575	78	+1.3%	Shares	Sole	2025-04-22
2024-12-31	$2,214	77	+20.3%	Shares	Sole	2025-01-31
2024-09-30	$1,791	64	+88.2%	Shares	Sole	2024-10-25
2024-06-30	$819	34	+385.7%	Shares	Sole	2024-07-15
2024-03-31	$189	7	0.0%	Shares	Sole	2024-04-30
2023-12-31	$194	7	-81.6%	Shares	Sole	2024-02-07
2022-09-30	$848	38	-61.2%	Shares	Sole	2022-10-21
2022-06-30	$2,919	98	+84.9%	Shares	Sole	2022-08-02
2022-03-31	$1,394	53	+130.4%	Shares	Sole	2022-05-02
2021-12-31	$534	23	—	Shares	Sole	2022-02-03
No filing history on record for this holder in this stock.